Your request has been received by DRG. A represantative will contact you shortly to provide more details on the research and data contained in this report and ensure that it will meet your current research needs.
The increasing emphasis on evidence-based practice in the US health care landscape has limited the growth of several key ENT device segments. However, continued innovation, particularly in alternative treatments such as drug-eluting sinus stents and balloon Eustachian tube dilation, will fuel overall expansion of the ENT device market.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for ENT devices in the US across a 10-year period.
Procedures performed in the office will rise over the forecast period.
What proportion of procedures are being performed in the office?
How will the rise in office-based procedures affect the competitive landscape and competitor strategies?
Despite slowing growth, the balloon sinus dilation market will remain lucrative through 2027.
What are the factors contributing to the slow down in growth?
How will growth differ between offices, hospitals, and ASCs?
How will the acquisition of Entellus Medical by Stryker affect the competitive landscape?
The introduction of innovative devices as alternative treatments for ENT conditions will drive overall market expansion.
How will drug-eluting sinus stents and balloon Eustachian tube dilation devices perform over the forecast period?
How has reimbursement for these devices improved?
What clinical trials are being conducted that could contribute to further growth?
Already a Client? Log in to access this report.
Xi Chen is a principal analyst on the Medtech Insights team at Decision Resources Group and currently serves as the in-house expert in general surgery, gastroenterology, ENT, and robotic surgery markets. Xi has been instrumental in improving the team’s market modeling capabilities and has also helped broaden the team’s expertise in leveraging medical claims and hospital purchase order data to perform market sizing and competitive analysis. Xi has been featured in several industry publications, particularly for his expertise in the robotic surgery market. Xi holds a in Biomedical Engineering from the University of Toronto.